With the increasing number of cancer patients and increasing interests of industry players, the global monoclonal antibodies market for oncology will witness a significant growth in coming years, says RNCOS.

1. Monoclonal Antibodies to Foresee Astounding Application in Oncology
With the increasing number of cancer patients and increasing interests of industry players,
the global monoclonal antibodies market for oncology will witness a significant growth in
coming years, says RNCOS.
According to our new research report, “Global Monoclonal Antibody Market Analysis”, the
market of monoclonal antibodies (mAbs) for the treatment of cancer has been growing
incessantly for the past few years. Our study indicates that due to high incidence &
subsequent potential for market success, cancer has effectively surfaced in attracting highest
levels of R&D. In fact, monoclonal antibodies therapeutics occupied around 30% of market
share in 2009 in the global oncology market.
We have identified some critical factors acting as a catalyst for the industry’s current and
future growth outlook. The report reveals that rising incidences of cancer coupled with
growing health insurance industry will drive renewed interests of the investors in the
monoclonal antibodies therapeutics market for oncology at the global level. Further, research
and development for expansion of usage of drugs for several indications will further enhance
the growth of mAbs oncology market in the coming years.
Besides, our report provides a thorough research and prudent analysis of Global monoclonal
antibodies therapeutics market. The systematic and thorough research studies the global
monoclonal antibodies therapeutics market to give an insight into its various segments,
including Oncology, Autoimmune & Inflammatory Diseases, Respiratory Diseases, Neurological
Diseases, and Cardiovascular Diseases. Further, the comprehensive analysis of the market at
the regional level, points the United States as the current highest share-holder. However,
future will see emerging countries like China & India posting significant growth rates.
"Global Monoclonal Antibody Market Analysis" provides thorough research and rational
analysis along with reliable statistics of the Global monoclonal antibodies therapeutics
industry. The report also provides extensive information on the traditional markets as well as
on the emerging technologies. Besides, an insight of trends prevailing at the regional
monoclonal therapeutics market segments across the globe along with analysis of key drugs
has been covered in the report. Analysis and statistics regarding market size, growth, share,
segmentation, and geographic distribution have been thoroughly studied in the report to give
a comprehensive view of the market. The report has thoroughly examined market drivers,
industrial developments, alliances & acquisitions, and competitive landscape to enable clients
understand the market structure and its future progress.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM279.htm
Check DISCOUNTED REPORTS on: http://www.rncos.com/promotion.htm
About RNCOS:
RNCOS specializes in Industry intelligence and creative solutions for contemporary business
segments. Our professionals study and analyze the industry and its various components, with
comprehensive study of the changing market behavior. Our accuracy and data precision

2. proves beneficial in terms of pricing and time management that assist the consultants in
meeting their objectives in a cost-effective and timely manner.
RNCOS E-Services Pvt. Ltd.
Shushmul Maheshwari
Chief Executive
B-129, Sector 6 Noida - 201301
91-120-4224-700
91-120-4224-707
press@rncos.com
http://www.rncos.com/
info@rncos.com
Keywords:
Global Monoclonal Antibodies Market, Global Monoclonal Antibodies Industry, Global
Monoclonal Antibodies Drugs, Global Monoclonal Oncology Market, Global Monoclonal Market
for Colorectal Cancer, Global Monoclonal Market for Breast Cancer, Global Monoclonal Market
for Lymphoma, Global Monoclonal Market for Leukemia, Global Monoclonal AIID Market,
Global Monoclonal Respiratory Diseases Market, Global Monoclonal Neurological Diseases
Market, Global Monoclonal Cardiovascular Diseases Market, US Monoclonal Antibodies Market,
Europe Monoclonal Antibodies Market, Japan Monoclonal Antibodies Market, China Monoclonal
Antibodies Market, India Monoclonal Antibodies Market, Roche, Johnson & Johnson, Merck,
Pfizer, Abbott, GSK